In 2016, Shanghai Fosun, a Chinese company, entered into an agreement to buy Gland Pharma, a Hyderabad-based generic injectibles pharmaceutical company, for $1.3 billion. A year later, the deal is yet to get approval from the Cabinet Committee on Economic Affairs or CCEA. It has been cleared by the ... (Publication: Business Today)
↧